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COMMISSION  OF  THE  EUROPEAN  COMMUNITIES 
OQM(93)  224  final 
Brussels,  24  Uay  1993 
COMl\IDNICATION FROM THE COMMISSION 
on collaboration between the Commission of the European Communities 
and the World Health Organization PREAMBLE 
The Council and the Ministers for Health meeting within  the Council have requested 
the  Commission  on  a  number  of occasions  to  present  an  up-to-date  review  of activities 
undertaken in the context of its cooperation with the .World Health Organization (WHO). 
In  response  to  these  requests,  the  Commission  has  prepared  the  present 
Communication on  the collaboration  between  the  Commission of the European  Communities 
and  the WHO.  This  Communication  surveys  the  various actions conducted  either jointly by 
the European Community and  the WHO, or with  the involvement of either party in  an  action 
undertaken by the other, grouped  under broad areas of activity which reflect distinct areas of 
policy of the European Community. 
2 INTRODUCTION 
Cooperation between  the  Commission of the  European  Communities and  the  WHO 
has been based on  two exchanges of letters between the Commission and the WHO Regional 
Committee for Europe in  1972,  and  the European Communities and  the WHO in  1982 (1). 
More recently the Director General of the WHO proposed the  reinforcement and extension 
of cooperation  between  the  two  organisations  and  a  letter  of intent  was  signed  by  the 
Director-General  of DG  I  for  the  Commission  and  the  Deputy  Director-General  of the 
WHO.  A  personal  representative  of the  Director-General  of the  WHO  to  the  European 
Community was  appointed  in  April  1992.  As  recently as September  1992,  at the  Regional 
Committee meeting, the Member States of the European region of the WHO expressed their 
wish  for closer relations between the various international organisations dealing with  health 
matters. 
In  the interests of cooperation and aware of the important contribution of the Member 
States of the  European  Community  to  the  policies,  programmes  and  budget of the  WHO 
(their assessed contributions amounted  to  30.16%  of the overall  WHO budget for  the  1992-
1993 biennium)  , the Council and the Ministers for Health  meeting  within the Council have 
from  time to time expressed the need for the Community to  cooperate more closely with  the 
WHO in  health-related  matters.  In  December  1990 the Council took note of a Commission 
staff working  paper outlining  the  various  areas  in  which  cooperation  with  the  WHO  was 
taking place. 
It should  be  noted  that  Article  129  of the  Treaty  on  European  Union,  currently 
undergoing  the  process  of  ratification,  and  in  particular  its  paragraph  3,  requires  the 
Community to foster cooperation with  international organisations competent in  the sphere of 
public health,  including the WHO.  Cooperation with  the WHO already covers a wide field, 
reflecting  shared  objectives  and  common  areas  of activity  .  It is  based  on  good  working 
relationships on common subjects of importance to obtain the best results from  the resources 
available and avoid duplication of effort,  rather than the implementation of common plans of 
action  agreed  between  the  two  parties.  Cooperation  takes  place  at  many  different  levels 
ranging  from joint participation  in  technical  working parties and  the exchange of technical 
information to  participation by  the  Commission as  observer at the World  Health  Assembly 
and the meetings of Regional Committees. 
Technical cooperation  has  been  particularly  strong  in  the  fields  of cancer,  chemical 
safety and  the setting of standards. It has  taken,  in  particular,  the form of joint conferences 
and  meetings  of experts  as  well  as  joint  publications.  In  the  important  areas  of  health 
promotion and  health  protection, joint activity has  been developed on  AIDS,  including joint 
support for  the  European  Centre for  the  Epidemiological  Monitoring of AIDS  (CEC/WHO 
collaborating  Centre  on  AIDS)  in  Paris,  health  education  in  schools  and  programmes  to 
combat smoking and addiction. 
(I)  OJ  N" LJOO. 28.10.19112. 
3 It is  important  to  note  the  growing  cooperation  between  the  Community  and  the 
WHO  in  the  area  of  humanitarian  and  development  aid,  based  on  complementary 
contributions  from  the two organisations.  On  the one hand,  the Commission is one of the 
major  aid  donors  in  the  world  and  health  provision  is  included  in  its  development 
programmes.  On  the  other  hand,  the  WHO  has  developed  standard  interventions  and  a 
country-based  approach  which  tits  well  with  the  Commission's  programmes.  Cooperation 
takes place in  the area of health-related assistance to  developing countries, cooperation with 
the  emerging  democracies  of Central  and  Eastern  Europe  and  the  former  USSR,  and 
emergency humanitarian aid  to countries afflicted by disasters and epidemics - such as Peru 
and Haiti  - and by internal disorder - such as  Bosnia-Herzegovina and the U.N. controlled 
area of Croatia. Here the Commission, in addition to the direct provision of medical supplies 
to hospitals through  the WHO,  is  a  major contributor to the activities of non-governmental 
organisations, which are supported by  the WHO. 
The  Community's  health-related  research  programmes  on  , such  subjects  as 
biomedicine and  health,  health  informatics,  AIDS  and  tropical  diseases  provide significant 
support to  the various areas of cooperation  between  the  Community and  the WHO.  They 
draw on the expertise of the WHO and its participation as appropriate. 
This  paper  presents  the  areas  of current  cooperation  under  five  main  headings : 
prevention,  health promotion and  education  ; standards,  labelling and  classification  ; health 
aspects  of the  environment  ;  aid  and  assistance  (including  cooperation  with  Eastern  and 
Central Europe) and research.  Conclusions are set out in  the last section. 
I.  PREVENTION, HEALTH PROMOTION AND EDUCATION 
PREVENTION OF MAJOR DISEASES AND DRUG ABUSE 
Cooperation between the Commission and  the WHO in  this area has been continuous 
since the beginning of the Community's programmes and activities on the basis of reciprocal 
attendance at meetings, exchanges of information and the provision of expertise. 
CANCER 
In  planning  and  implementing  the  EC  "Europe  against  Cancer"  programme  the 
Commission  drew,  inter-alia,  on  the  long  experience of the  WHO  in  combatting  cancer. 
Cooperation between the two organizations now has a double objective : 
- the search for common policies, exemplified by the fight against tobacco , including 
the  joint Organization  of the  First  European  Conference  on  tobacco  prevention  policies 
(Madrid,  1988)  and  the  World  conference  on  tobacco  and  health  (Paris,  1994),  cross 
representation at meetings and Commission participation in  the WHO No Tobacco Day. 
- the development of common  initiatives such  as  those in  the fields  of nutrition and 
epidemiology.  To examine  the  relationship  between  nutrition  and  cancer,  the  Commission 
proposed  and  financed  a  European  network  coordinated  and  managed  by  the  WHO 
International  Agency  for  Research  on  Cancer  (IARC).  IARC's work  includes  prospective 
surveys and  the  Organisation  of an  International  Congress on  Nutrition and  Cancer (Lyon 
1993) and it has contributed to a meeting on  the same subject in  Budapest in  June 1990.  In 
the  same  way  recommendations  on  the  training  of oncologists  developed  at  conferences 
under the EC  programme have been  the basis  for  a  WHO meeting on  the  same subject in 
Prague in  1992. 
4 AIDS 
The formation of a network of cancer registries, an  IARC initiative,is now supported 
as  part of the  Community Cancer programme and  makes  a  very  important contribution  to 
cancer  epidemiology  and  other  studies.  Similarly,  !ARC's  evaluation  and  monograph 
programme on carcinogens is supported by  the Commission. 
The extent and  seriousness of the threat posed  by  the  AIDS  pandemic has  required 
and will continue to require close cooperation between the Community and the WHO. 
The  action  programmes  developed  by  the  Commission  are  consistent  with  the 
coordinated strategies adopted  by  the  WHO and  implemented by  its  Global  Programme on 
AIDS, and are intended  to  provide a  distinct Community contribution. The Commission  is 
invited to attend the Management Committee of the the WHO Global Programme on AIDS 
and  has played an  active part in  the  definition of the  strategies.  Those responsible  for  the 
Community action programmes maintain close contact with  their counterparts in  WHO and 
share activities where appropriate. 
The Commission and the WHO cooperate closely to support the European Centre for 
the  Epidemiological  Monitoring of AIDS  in  Paris,  which  is  the  central  institution  for  the 
collection of pertinent data  in  Europe and  provides excellent  up  to  date information and  a 
framework for other joint activities. 
The Commission has initiated a joint programme with WHO to test indicators of the 
performance and  efficacy  of national  programmes to  combat  AIDS.  The Commission  has 
participated with WHO in  technical  meetings organised by the WHO on particular aspects of 
AIDS  prevention  such  as  Sexually  Transmissible  Diseases  (STDs)  and  the  Global  Blood 
Safety  Initiative.  Furthermore  there  has  been  a  joint  involvement  in  the  International 
Conferences on AIDS (Firenze 1991  and Amsterdam  1992). 
The  possible  development  of  a  major  epidemic  in  Eastern  European  countries 
provides  a  further  incentive  for  reinforced  cooperation  between  the  Commission  and  the 
WHO , both being aware of the potential seriousness of the situation. 
DRUG ABUSE 
Cooperation between the Commission and  the WHO in  this area is  confined to drug 
demand reduction and health education. The WHO has global scientific responsibility for the 
definition  of  narcotics  which  is  carried  out  exclusively  by  its  Expert  Committee  on 
Drugdependence, but its  further involvement in  drug abuse is  limited to  demand  reduction. 
In  contrast to other areas of public health,  the WHO is not involved in  treatment, control or 
enforcement. 
One of the tasks of the European  Monitoring  Centre for  Drugs and  Drug  Addiction 
(EMCDDA)<1)  ,  is to promote the incorporation of data on drugs and drug addiction gathered 
in  the Member States or by the  Community into international  monitoring and drug-control 
programmes,  particularly  those  established  by  the  United  Nations  Organization  and  its 
specialized agencies (such as the  WHO), and to cooperate actively with  such organisations. 
The WHO has  expressed  the  wish  to  co-operate  with  the  EMCDDA  in  the  coiiection  of 
epidemiological data. 
( 1) Council Regulation N ° 302/93 of 8 February  19'13  on the cstahlishmenl of  a  European Monitoring Centre for Drugs and  Dru;;  At!Jiction (OJ  L 36. 
12.  2. 1993. p.l). 
5 HEALTH EDUCATION AND PROMOTION 
Collaborative  work  with  the  WHO  and  the  Council  of Europe  to  promote  health 
education and the prevention of drug abuse,  AIDS,  cancer and  other major diseases which 
has  taken  place  for  a  number  of years  is  now  growing  in  scope  and  importance.A joint 
Conference on  the  Promotion of Education  for  Health  was organised in  1990 in  Strasbourg 
by  the three organisations to  promote health education efforts in the field of drug prevention 
and  the  Commission  worked  with  the  WHO  in  the  preparation  of a  number of Summer 
Schools  for  teacher  training  in  Health  Education  (e.g.  Southampton  (1990),  Montpellier 
(1991),  Flensburg(l991),  etc.).The  Commission,  the  WHO  and  the  Council  of Europe 
collaborate in the European Network of Health Promoting Schools. 
HEALTH AND SAFETY AT WORK 
The  Commission  is  cooperating  with  the  WHO  in  the  development  of indicative 
criteria  for  the  training  of competent  persons  in  the  various  disciplines  concerned  with 
occupational  health  and  safety  and  supports  their  initiative  for  the  development  of the 
supporting services in  occupational medicine, hygiene and safety. 
The Commission  participates  in  a  IARC  project on  harmonization  of methods  and 
quality  assurance  in  the  evaluation  of  exposure  to  airborne  contaminants  in  the  work 
environment  - asbestos  and  other  health  risk  related  fibres.  It  also  assists  with  some  of 
1/\RC's epidemiological studies such  as the assessment of risks in  laboratories. 
In  view  of the  urgent  need  for  more  international  cooperation  on  the provision  of 
scientific data to be  used  for assessing effects due to chemical  agents in  the workplace,  for 
example for  the  setting  of limit  values,  a  number of joint activities  on  the  evaluation  of 
hazardous chemicals at the workplace are taking place. 
Some of these activities draw on a systematic approach to labelling and classification 
(see section II Standards,  labelling and classification) and on evaluations of toxicity carried 
out under the International Programme on Chemical Safety (IPCS) which has been set up by 
the  United  Nations  Environmental  Programme  (UNEP),  the  International  Labour 
Organisation (ILO) and WHO. 
Also within the framework of the IPCS, the Commission supported the production of, 
"Chemical  Safety  Cards"  which  provide  basic  information  to  workers  and  other users  of 
chemicals  on  health  hazards  and  the  precautions  to  be  taken.  The  Commission  also 
contributes  expertise  in  the" elaboration  of  the  IPCS' s  Environmental  Health  Criteria 
documents. 
6 H.  STANDARDS, LABELLING AND CLASSIFICATION 
This area of cooperation  provides  a  good  example of complementarity  in  that  the 
WHO  is  not  a  regulatory  agency  but  can  provide  scientific  evaluations  and 
recommendations, validated by  independent neutral groups of experts. This complementarity 
has  led  to  close  cooperation  with  the  WHO  in  a  number  of  areas  e.g.  chemicals, 
carcinogens, medicinal products and foodstuffs. 
In  the context of the IPCS  and  as a  follow-up  to  one of the objectives identified  in 
Chapter  19  of  Agenda  21  of  the  United  Nations  Conference  on  Environment  and 
Development (UNCED 92), the Commission is currently collaborating with WHO and other 
international organisations to investigate common approaches towards the classification and 
labelling of chemicals placed  on  the  market and  used  at  work.  Community interest in  this 
area is  based  upon  Directive 67/548/EEC(ll  (as  amended)  on  the classification,  packaging 
and labelling of dangerous substances. 
Technical support has  been given by the WHO (IARC) to  the CEC group of experts 
working  on  classification  and  labelling  of  carcinogenic  substances  (Council  Directive 
67/548/EEC <1>)  and to the Commission's practical short monographs on carcinogens. 
In  the field  of pharmaceutical legislation and biological standardization,  the WHO is 
increasingly  basing  its  international  harmonisation  activities on  Community guidelines,  for 
example  EC  good  manufacturing  practice<2l  and  EC  requirements  for  biotechnology 
medicines<J>  < 4> ,  while  the  WHO certification  scheme  for  the  quality  of pharmaceuticals 
exported  to  third  world  countries  has  been  officially  adopted  by  the  Community<5> .  The 
WHO has  been  invited  to  take  part in  trilateral  discussions  (USA/Europe/Japan) leading to 
better  pharmaceutical  harmonisation  at  world  level.  Co-operation  with  the  WHO  on  the 
surveillance  of  side  effects  ("pharmacovigilance")  and  in  the  field  of  the  European 
Pharmacopoeia has also been established. 
The Commission participates in  the work of the FAO/WHO Codex Alimentarius, and 
is  spokesman  for  the  Community  in  matters  belonging  to  the  external  Community 
competence.  This Codex,  which  is  developed  by  the  United  Nations Food and  Agriculture 
Organization and  the  WHO,  revises  and  updates  the  international  standards  on  foodstuffs. 
The WHO, as co-secretary of the Codex, is also responsible for  the scientific evaluation of 
risks  related  to  food  additives  and  residues  (whether  they  are  of veterinary  or  pesticide 
origin).  Independent  committees  of  scientific  experts,  in  which  the  Commission  is 
represented, are used  for this work. 
The  WHO  Code  of  the  Marketing  for  Breast-Milk  substitutes  has  been  largely 
implemented in  the  Community through  the Commission  Directive 91/321/EEC  (6)  and  the 
Community  will  contribute  to  its  application  in  third  countries  following  the  adoption  of 
Council Directive 92/52/EEC (7) and Council Resolution 92/C 172/01  (SJ 
(I) Counc:l Directive of 27 June 1967 on the approximation of laws.  r~gulations and administrative rrovisions relating to the classilication. packaging 
and labelling of  dangerous substances (OJ  196,  16. 8.  196  7. p .l). 
(2) Commission Directive of l3 June 1991  laying down the  prin~ipks and guiddincs of  good manufacturing practice for medicinal products for human 
usc (OJ  L  193,  17. 7.  1991, p.30). 
(3)  Council Directive of 22 December 1986 on the approximation of national  measures relating to the placing on the market of high-technology 
m~dicinal products, particularly those derived from biotechnology (OJ  L  15,  17.  I. 1987, p.38). 
(4) Commission Directive of 19 July 1991  modifying the  Ann~x to Council dircctiv~ 751318/EEC on the approximation of the Jaws of Member States 
rdating to analytical.  pharmacotoxicologi~al and dini~al stllndards lind  protocols in respect  ofth~ testing of medicinal products (OJ  L 270. 26. 9. 
IY9]. p.32). 
()) Council  Di~ctive of 3 May  19M9  am~nding Directives 6)/oS/EEC. 75131ll/EEC a  !Ill  751319/EEC on U>~ arproximation of prnvisions laid down hy 
law. regulation or administrativ~ action relating to propri~tary m~dicinal products (OJ  L 142, 25. 5. 1989, p.ll). 
(6) Commission Directive of 14 May 1991  on infant fonnula~ ami  follow-on  fonnula~ (OJ  L 175, 4.7.1991, p.35). 
(7) Council  Dire~tivc of 18 June 1992 on infant  formula~ and follow-up  formulae  int~nded for export to third countries (OJ  L  179,  ] .7.  1  <l'i2,  p. ]'2· 
(8) Council  R~solution of 18 June 1992 on the marketing of breast-milk substitutes in third countries by Community based  manufactur~r" (Oc  '· · : 7L 
7.  1992,p.l). 
7 III.  HEALTH ASPECTS OF THE ENVIRONMENT 
Since the addition  in  1986 of Title VII  "Environment"  to  the Treaty establishing the 
European  Community  and  the  first  European  Conference  on  Environment  and  Health 
(Frankfurt  1989)  cooperation  between  the  Commission  and  the  WHO on  health  aspects of 
the  environment  has  intensified.  The  Commission  and  the  WHO  are  currently  working 
together  on  the  follow-up  to  the  United  Nations  Conference  on  Environment  and 
Development (Rio de Janeiro,  1992). This work is confined to  the effects of environmental 
factors on  human health,  in  conformity with  the WHO's mandate.  The Council and Health 
Ministers meeting in  Council also adopted this approach when requesting the Commission to 
prepare a report on existing knowledge and experience concerning the relationship between 
health and  the environment (Resolution  91/C 304/06 of November  1991  on  health and the 
environment). 
TOXICOLOGY 
The European Community's programme of action on  toxicology  for health protection 
(Council Resolution 86/C  184/0 l) calls for the development and  assessment of toxicological 
methods to support Community actions in  the field  of chemical safety.  Joint activities with 
the WHO have been carried out in  the following areas : role of poison centres, evaluation of 
antidotes including chelating agents, e.g. for cyanide and  heavy metal poisoning, toxicity of 
chemicals for children,  principles for  the assessment and early detection of nephrotoxicity, 
and health risks of chemicals to progeny during pregnancy. 
A  joint  workshop  was  also  held  on  the  health  significance  of  immunotoxicity 
(Hannover,  1989).  The  Commission's  Scientific  Advisory  Committee  to  Examine  the 
Toxicity and Ecotoxicity of Chemical Compounds is involved in  a WHO activity on allergic 
hypersensitivity to chemicals. 
RADIATION PROTECTION 
Cooperation  with  the  WHO  on  radiation  protection  takes  place  through  an  Inter-
Agency  Committee  on  which  a  number  of  international  organisations  including  the 
International  Atomic  Energy  Agency  (IAEA)  and  the  Nuclear  Energy  Agency  of the 
Organisation  for  Economic  Cooperation  and  Development  (OECD)  are  represented.  The 
objective of this informal cooperation is to promote consistency and co-ordination of policies 
with  respect  to  fundamental  aspects  of radiation  safety  (including  principles,  criteria and 
standards)  and  their  transformation  into  regulatory  terms;  co-ordination  of research  and 
development;  education  and  training;  promotion  of  information  exchange;  transfer  of 
technology and know-how ; and the provision of radiation safety services. 
AIR. WA7ER AND AGRICULTURE 
Cooperation takes place between the Commission and the WHO on  air quality.  The 
Commission  provides  GEMS  (Global  Environment  Monitoring  System  - WHO/UN 
Environmental  Programme)  with  data  collected  under  the  exchange of information  on  air 
pollution  established  by  Council  Decision  82/459/EECO>  .  The  WHO  is  responsible  for 
ascertaining the needs and  wishes of policy makers in  the field  of air pollution and  for the 
provision of the necessary scientific background. 
(I) Council Decision of24 June  1982 establishing a reciprocal exchange of infonnatinn and dalll  from networks and individual stations measuring air 
pollution wilhin lhe Member States. (OJ  L 210.  19.  7.  19!12.  p.l). 
8 The Commission attends WHO consultations in other areas sur.;h  as  the revision of 
WHO guidelines on drinking water quality  ;  rabies  eradication  ;  zoonoses and foodbome 
infections (the last with the WHO collaborating centre in Berlin). The Commission took part 
in  a  joint FAO!Pan  American  Health  Organization/WHO  teclmical  consultation  on  food 
safety and commercialisation (Buenos Aires,  April 1992) following the cholera epidemic in 
Latin America. 
The  European  Community  participated  as  a  full  member  in  the  International· 
Conference on Nutrition (ICN) which was organised jointly by FAO and WHO and was held 
in Rome in December 1992. The Commission co-ordinated the Community positions  with 
the Member States throughout the Preparatory Conferences and the ICN itself. This allowed 
the  Community  to  have a  major  part in  the  outcome  of the  Conference to  which  the 
Commission contributed also financially.  The Conference unanimously approved the "World 
Declaration on Nutrition  n and the "Plan of Action for Nutrition II. 
ENYTRONMEl::II_AND_ HEALTH 
The Commission is providing support to WHO in the organisation and  realisation of 
the Second European Conference on Environment and Health (Helsinki, June 1994), which 
will  be hosted by  the Government of Finland. This Conference, is a follow-up  to the first 
Conference  (Fcinkfurt-am-Main,  December  1989)  at  which  a  "European  Charter  on 
Environment  and  Health"  was  adopted  jointly  by  the  participating  Ministers  of the 
Environment and Health and signed by the Commission in  the name of the Community. The 
main objective of the second conference is to adopt an action plan on prevention and control 
of environmental health hazards up to the end of the century. 
IV.  COOPERATION AND DEVELOP:MENT AID 
DEVFLOPMENT  ASSISTANCE 
Cooperation in  the area of development assistance is of a multilateral kind developed 
pragmatically through joint missions and joint ventures. 
Good examples of such cooperation are : 
joint health expenditures reviews 
- Bangladesh.  where the WHO is the executive body for a health programme which is 
co-financed by the World Bank, the Community and its Member Stmes 
and Benin, where the WHO advises the government while the Commission chairs the 
group of donors. 
.  The Commis~on takes account of the recommendations of the WHO in  establishing 
Its  ~wn general  ~licy and  as  ~ards some  of the  technic:al. aspectS  of  ~ts interventions 
(policy on health d1stncts, essential drugs, etc.). The ComrrusSlon  works wtth the WHO i11 
developing countries where the WHO is represented, attends the WHO conferences  and ha!: 
meetings  ~th the WHO programl?e staff.  In the field,  delegations and  consultants  mak~. 
contact wrth the WHO representatlves  most frequently when projects are being iden1ifi:.{  .. 
The programme to  combat onchocerciasis in  Africa funded  by  the Community  and  :~~,··  ·· 
bodies, is executed by the WHO. 
9 In  implementing the  programme for the fight against AIDS  in  third-world countries, 
cooperation  and  coordination  of the  Commission  with  the  WHO  within  the  scope  of the 
WHO Global Programme on  AIDS, aims for joint definition of strategies, agreement on the 
definition  of  short  and  long-term  programmes  in  particular  countries  and  coordinated 
execution of programmes at country level. 
Within  the  framework  of  the  short- and  long-term  national  programmes  the 
Commission  acts  in  liaison  with  the  countries  concerned  and  other  financial  supporters. 
Recent joint Commission/WHO activity  in  the  field  of AIDS  has  included  a joint review 
mission in  Thailand  ; ad  hoc  meetings for operational coordination on India and Thailand ; 
co-organisation and  financing  of regional  meetings in  Dacca,  Delhi,  Caracas and  Yaounde 
and of training courses for programme managers in  Dakar and  Antwerp  ; and  special joint 
research  projects  on  AIDS  between  scientists  from  EC  Member  States  and  developing 
countries. 
The external evaluation report of the programme to combat AIDS, drawn up in  1992 
to  define  new  guidelines  for  the  programme  within  the  framework  of  the  Lome  IV 
Convention,  endorsed  the  general  approach  adopted  by  the  Commission.  It recommended 
continued coordination with  the WHO Global  Programme on  AIDS,  while ensuring that the 
methodologies adopted and  actions proposed  fitted  well  with  those defined  by  the National 
Committees. 
COOPERATION WITH EAST AND CENTRAL EUROPE AND THE REPUBLICS OF THE FORMER 
USSR 
The  Commission's  technical  assistance  programmes  "PHARE"  and  "TACIS"  are 
intended  to  provide  support  for  the  economic  restructuring  of the  countries  of East  and 
Central Europe and the former Soviet Union.  Work in  the health sector has been growing in 
importance and  has  consequently  involved  cooperation  with  the WHO and other interested 
· international  organisations  such  as  the  World  Bank  and  the  European  Bank  for 
Reconstruction  and  Development.  At  the  Washington  and  Lisbon  conferences  (1992)  on 
assistance to  the Republics of the former USSR,  the WHO participated in  the medical  sub-
group and  was  invited  to  establish  a clearing  house on  the health  needs of those countries 
and  the  response being  made  to  them.  The WHO  has  also  been  requested  in  a  number of 
cases to provide assistance particularly in  the form of expert missions and evaluations and  to 
help  the  Governments  of the  countries  concerned  to  formulate  their  new  priorities  and 
policies. 
Technical support has been  provided by the Commission in  workshops set up  by  the 
WHO to explain the requirements of EC  legislation  to  Central and  Eastern European States 
on  such  subjects  as  safety  and  health  at  work.  Similar arrangements  have  been  made  to 
present the Community's policies and programmes in  the field  of prevention of diseases and 
drug addiction. 
HUMANITARIAN EMERGENCY AID 
The Commission  has  set up  internally,  with  effect from  I  March  1992,  a  European 
Office  for  Emergency  Humanitarian  Aid  (ECHO).  This  development  is  intended  among 
other  things  to  improve  coordination  between  the  Commission  and  Member  States,  other 
donors, non-governmental (NGO) and international organisations, including the WHO. 
Cooperation between the Commission and the WHO in  the provision of humanitarian 
aid has taken place mainly in Central and South America and Eastern Europe. 
10 The Commission  has  been  providing  regular financial  support to  the WHO medical 
programmes  in  Latin  America,  the  most  recent  examples  being  the programmes  in  Peru 
related to cholera and in  Haiti to alleviate the shortage of medicinal products. 
In  Europe the substantial  humanitarian  aid activities of the Commission through  the 
WHO  have  focussed  on  Bosnia-Herzegovina  and  the  UN  controlled  areas  in  Croatia, 
providing medical  kits  to  hospitals.  In  addition,  while the  NGO health  programmes in  the 
area  are  supported  by  the  WHO,  the  Commission  is  a  major  contributor  to  the  NGO 
activities. 
V.  RESEARCH 
EC MEDICAL AND HEALTH RESEARCH 
The research  objectives  of the  Community  and  the  WHO  complement  one  other 
within the broad spectrum of research related  to  medicine and health. The Community aims 
to improve the efficacity of medical and  health research  in  Member States,  in  particular by 
better coordination of their activities and  in  the application of results  through  Community 
cooperation and the pooling of resources. 
Cooperation  between  the  Commission  and  the  WHO  in  the  field  of medical  af1d 
health research has taken place at different levels, including programme formulation,  project 
management and technical levels. 
To ensure that  constructive collaboration  occurs at  programme formulation  level  it 
has  been  agreed  that  planning  seminars  would  be  jointly  organised  at  which  research 
priorities  were  identified.  Further  collaborative  action  took  place  through  information 
exchanges, personal relationships with  key  members, participation in  meetings (in  particular 
concerning planning activities) and joint workshops. 
The WHO European  Advisory  Committee  for  Health  Research  (EACHR)  has  been 
attended by observers from  the EC Management and  Coordination Advisory Committee on 
Medical and Health Research (CGC). As  the WHO European Region has a small operational 
research budget,  it was agreed  that  input from  the Region  would  be useful  to  the CGC in 
assisting with advice to the EC on priority setting and programme formulation. 
The WHO regularly attends  meetings of the EC Working Party on AIDS  Research 
and its subgroups, and also those of the Concerted Action Committees (COMACs) on Health 
Services Research and on Epidemiology. Project leaders of EC concerted actions have direct 
technical  contacts  with  the  WHO  programme  leaders.  This  has  contributed  to  the 
development  of  joint  collaborating  centres  such  as  the  European  Centre  for  the 
Epidemiological  Monitoring of AIDS  (in  Paris) and  the  EtJROCAT Centre (in  Brussels) for 
the  registration of congenital ahnor111alitics. 
HEALTH CARE INFORMATICS AND TELEMATICS 
The  Commission  administers  the  Advanced  Informatics  in  Medicine  (AIM) 
Exploratory Action,  and  from  1988  to  1990 received  much  support for  it from  the  WHO, 
both  with  respect  to  epidemiological  data  and  the  definition  of performance  and  quality 
assessment criteria to  be  integrated  in  health  informatics systems.  Individual  projects  have 
worked  with  the  WHO,  as  the  coordinating  partner,  on  oral  health  and  on  chronic  cr.re 
management, in  particular for diabetes. 
11 In  the  EC  Research  and  Development  Programme  on  Telematics  Applications  of 
General  Interest  (3rd  Framework  Programme,  1990-1994),  the  WHO European  Region  is 
collaborating in  4 of the 37 projects administered by  AIM.  These concern the improvement 
of quality assurance in  using telematic tools and the definition of European reference models 
to  improve the effectiveness of community  and  primary health  care services  by  means  of 
specific telematic products. The WHO is the co-ordinating partner for the ORA  TEL project, 
which  aims  to  develop  a  European  telematic  tool  for  education  and  training  in  quality 
assurance for oral health care. The WHO brings its European knowledge of the community 
and  primary  health  care  sectors  to  other  partners  in  ISAAC  (an  information  processing 
. system  relating  to  those  sectors),  in  QUICHE  (a  telematics-based.  quality  assurance 
programme for child health  services,  and  in  SHINE (an  informatics community health  care 
network in Europe). 
Within the ENS (European Nervous System) area of the Telematics Programme,  the 
WHO is the coordinating partner for the CARE project.  A major part of ENS is directed at 
identifying and defining a transeuropean  communications network for administrations.  The 
CARE  project  will  provide  fast  and  effective  access  to  health  statistics  for  national 
administrations through the use of telematics networks. 
The WHO also participates in  Commission initiatives to  develop telematic networks 
relating to the workplace. 
DEVELOPMENT RELATED RESEARCH 
The  Community  Programme  "Life  Sciences  and  Technologies  for  Developing 
Countries"  (STD)  cooperates  with  various  WHO  programmes  on  the  basis  of regular 
consultations  especially  with  WHO's  Special  Programme  for  Research  and  Training  in 
Tropical  Diseases  (TDR),  WHO's  Global  Programme  on  AIDS,  and  the  WHO  Special 
Programme of Research,  Development and Research Training in  Human Reproduction. The 
Commission  is  represented  in  the  joint  Coordinating  Board  of TDR  and  in  the  WHO 
Management Advisory Committee for the Children's Vaccine Initiative. 
The Community STD  Programme was  involved in  the preparatory meetings for  the 
WHO's  Global  Ministerial  Conference  on  Malaria  (Amsterdam,  October  1992),  and  has 
participated in the Conference itself and its follow-up. 
Furthermore collaboration  is  increasing  between  the  WHO,  CEC and  other private 
and public development bodies in areas of common interest such as vaccine development and 
disease control strategies. 
CONCLUSIONS 
Cooperation and  mutual  understanding between  the Commission and the WHO,  first 
·formally recognized in  1972,  has improved and developed in  recent years, extending both in 
scope and depth. Further initiatives and joint projects are under consideration and other areas 
of possible cooperation are being identified. 
The ratification  of the  Treaty  on  European Union and in  particular paragraph  3 of 
Article 129, which requires the Community to foster cooperation with third countries and the 
competent international organisations in  the sphere of public health,  will  have an important 
bearing on the scope and  form of such future relations between the Community and WHO. 
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